Skip to main content Accessibility help

We use cookies to distinguish you from other users and to provide you with a better experience on our websites. Close this message to accept cookies or find out how to manage your cookie settings.

Close cookie message
×
  1. Home
  2. Search

Refine search

Refine search

Access:
Content type:
Publication date:
Apply   From and To filters
Subject: Show more
Journals Show more
Publishers: Show more
Societies Show more
Series: Show more
Collections: Show more

Actions for selected content:

Select all | Deselect all
  • View selected items
  • Export citations
  • Download PDF (zip)
  • Save to Kindle
  • Save to Dropbox
  • Save to Google Drive

Save Search

You can save your searches here and later view and run them again in "My saved searches".

Please provide a title, maximum of 40 characters.
Cancel
×

1 results

  • Appendix I: - Treatment Guidelines

  • Edited by Elias Aboujaoude, Stanford University School of Medicine, California, Lorrin M. Koran, Stanford University School of Medicine, California
  • Book:
    Impulse Control Disorders
    Published online:
    06 July 2010
    Print publication:
    08 February 2010, pp 275-279

  • Summary

    This chapter deals with clinical aspects of problematic Internet use. It suggests that formal diagnostic criteria would enhance recognition of and research regarding problematic Internet use. Factor analysis extracted six factors from the Internet Addiction Test (IAT): salience, excessive use, neglect of work, anticipation, lack of control, and neglect of social life. These six factors strongly correlated with each other and showed good to moderate internal consistency. Caplan has described the Generalized Problematic Internet Use Scale (GPIUS), which was reliable and valid in a preliminary study. Patients' Internet use often appears to become problematic soon after they first use the Internet, possibly within 6 months to a year a time when they feel intimidated as well as fascinated by the new technology. Problematic Internet use may respond to serotonin reuptake inhibitors, although larger and longer controlled trials are needed to investigate this possibility.